Although often regarded as a protean illness with myriad clinical and imaging
manifestations, neurosarcoidosis typically presents as recognizable syndromes that can be …

The focus of this review is current knowledge about the epidemiology, clinical
manifestations, diagnosis, and treatment of both pulmonary sarcoidosis and extrapulmonary …

Sarcoidosis is a multisystem granulomatous disease with nonspecific clinical manifestations
that commonly affects the pulmonary system and other organs including the eyes, skin, liver …

Background The soluble interleukin 2 receptor (sIL-2R) has been proposed as a marker of
disease activity in patients with sarcoidosis. However, no studies have evaluated whether …

Introduction: Sarcoidosis is a complex systemic disease with a silent, long-term evolution,
and a heterogeneous clinical presentation. The diagnostic approach is complex with no …

Background Serum chitotriosidase is a promising biomarker that has shown high specificity
and sensitivity in patients with sarcoidosis. The aim of this study was to investigate …

Purpose. Sarcoidosis is a systemic granulomatous disease with unknown etiology. Many
clinical presentations have been reported, and acute disease needs to be distinguished …

Neurosarcoidosis is an uncommon manifestation of sarcoidosis that is associated with
significant morbidity and mortality. Diagnosis of neurosarcoidosis is often challenging …

Objectives: Data on clinical manifestations and outcome of hepatic sarcoidosis are scarce.
This study aimed to use a population-based cohort of patients with incident sarcoidosis to …

Abstract Purpose of Review The purpose of this review is to provide a framework to
distinguish Blau syndrome/Early Onset Sarcoidosis and Sarcoidosis clinically. We also …